(Q43036087)

12 November 2017

title

A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C (English)

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

15 May 2024

1 reference

S. Takano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521313

15 May 2024

Y. Ito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521313

15 May 2024

O. Yokosuka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521313

15 May 2024

M. Ohto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521313

15 May 2024

K. Uchiumi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521313

15 May 2024

K. Hirota

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521313

15 May 2024

M. Omata

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521313

15 May 2024

language of work or name

English

0 references

publication date

1 September 1994

1 reference

full work available at URL

12 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.1840200303

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

https://onlinelibrary.wiley.com/doi/full/10.1002/hep.1840200303

15 May 2024

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

15 May 2024

1 reference

12 November 2017

volume

20

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

558-564

1 reference

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

12 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

15 May 2024

3

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant ?-interferon for chronic non-A, non-B hepatitis

15 May 2024

5

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

15 May 2024

6

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

15 May 2024

7

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

15 May 2024

9

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

15 May 2024

10

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis

15 May 2024

11

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids.

15 May 2024

13

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial

15 May 2024

18

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

15 May 2024

19

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy

15 May 2024

20

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study

15 May 2024

21

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

Effects of acute changes of bile acid pool composition on biliary lipid secretion.

15 May 2024

23

1 reference

https://api.crossref.org/works/10.1002/HEP.1840200303

15 May 2024

Identifiers

10.1016/0270-9139(94)90088-4

1 reference

12 November 2017

1 reference